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PREVIOUSLY it was shown (Baldwin, Cunningham, Partridge and Vipond,
1962) that substitution with methyl, hydroxy, or methoxy radicals in the 2-
position of tricycloquinazoline (TCQ; I, Fig. 1) causes almost complete loss of
carcinogenic activity. These findings imply the intervention of the 2- or equiva-
lent 7- or 12-positions of the TCQ molecule in carcinogenesis.
A direct three-point union ofTCQ to a cellular receptor at these positions could
occur however only by covalent bonding and thus the finding that TCQ is not
strongly bound in skin (Baldwin, Palmer and Partridge, 1962) excludes this
possibility.
Methyl substitution in the other three possible ring positions in TCQ, namely
1-, 3-, or 4-, only partially reduces carcinogenicity, and these derivatives possess
significant activities. Introduction of additional methyl substituents at the
positions equivalent to the 3- position, namely 8- or 13-, brings about a very
marked decrease in activity; thus both 3,8-dimethyl-TCQ and 3,8,13-trimethyl-
TCQ have very low activity. These findings suggest that stereochemical factors
are important and it is considered that the evidence relating structure to activity
in TCQ can be most logically accommodated in terms of the precision of stereo-
chemical fit of the planar carcinogen by multiple low-energy bonding to a planar
cell receptor site. In order further to assess the importance of molecular shape
for carcinogenicity, the effect of variations in the arrangement of the homocyclic
and heterocyclic rings of TCQ have been examined. The analogues tested for
carcinogenic activity following skin painting in mice included an isomer, iso-TCQ
(IV, Fig. 1) in which the position ofone benzene ring is altered so that the molecule
possesses neither a symmetrical structure nor the same distribution of nitrogen
atoms as in TCQ. This compound is basic and accordingly was examined as the
free base and as its nitrate. The hexacyclic compound (II, Fig. 1) was also tested
because of its similarity to iso-TCQ in being a base and because its molecular
shape is close to that of both TCQ and iso-TCQ. Furthermore, an oxygen iso-
stere of iso-TCQ (V, Fig. 1) was examined since this compound, although
structurally related to iso-TCQ, resembles TCQ more closely in its feeble basic
properties.
A number of simpler azapolycyclic compouinds structurally related to TC(Q
were examined also to assess the importance of overall molecular size for carcino-
genicity. The compounds tested include a pentacyclic compound (VI, Fig.1)
which is equivalent to iso-TCQ less a benzene ring and quinazoline and 4-hydroxy-
quinazoline since these substanices may also be related to possible metabolites
of TCQ.CARCINOGENICITY OF TRICYCLOQUINAZOLINE
MATERIALS AND METHODS
Mice.-Stock male albino mice (Schofield strain), 6 to 8 weeks old at the start
of each experiment.
Skin painting.-Dorsal hair was removed by clipping at the beginning ofeach
test and subsequently when necessary. Mice were treated twice weekly for
approximately 12 months and then kept under observation until tests were ter-
minated (18 months). Mice were examined for the presence of tumours at
weekly intervals and were killed when it was considered that tumours were malig-
nant or when they were ill. The position of all tumours was then recorded and
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FIG. 1. Tricycloquinazoline, structural analogues and related compounds.
specimens ofskin, skin tumour and other organs showing gross pathological change
were taken for histological examination.
Details ofcompounds
The azapolycycic compounds tested all bore certain structural resemblances
to known carcinogens, as illustrated in Fig. 1. Thus compounds II to VI are
evidently structurally similar to TCQ (I), whilst the triazabenzanthracene (VIII)
resembles a 10- substituted 1,2-benzanthracene (VII). Similarly the phenanthro-
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line (X) resembles 3,4-benzophenanthrene (IX), whereas quinazoline (XI) and
4-hydroxyquinazoline (XII) could be related to possible metabolites of TCQ.
The syntheses and properties of these derivatives have been described pre-
viously (Butler, Partridge and Waite, 1960; Parfitt, Partridge and Vipond, 1963;
Partridge and Vipond, 1962). For carcinogenic assay, all but iso-TCQ nitrate
were dissolved in double re-distilled, AR grade benzene. Because ofits unfavour-
able solubility in benzene, iso-TCQ nitrate was skin painted in 1: lv/v aqueous
acetone. Details of the total doses and concentrations at which the compounds
were tested are shown in Table I.
TABLEI. Details of Compounds Examined
Concentration Total
tested dose
Compound mg./ml. (mg.)
Tricycloquinazoline (TCQ) . 1-0 . 24
Compound II . . . 1.0 30
Tri-o-xylylamine (III) . 5-0 100
Iso-TCQ. Free Base (IV) . . 1-0 30
Iso-TCQ Nitrate (in aqu. . 1.0 31
acetone)
CompoundV . . . 1-0 33 CompoundVI . . . 1*0 31
Triazabenzanthracene (VIII) . 25 53
Phenanthroline (X) . 10 30
Quinazoline (XI) . 5.0 100
4-Hydroxyquinazoline (XI) . . 10 30
RESULTS
The incidences of skin tumours following application of tricycloquinazoline,
structural analogues and related compounds to mouse skin are summarized in
Table II.
TABLE II.-Skin Tumour Incidences in Mice Treated with Tricycloquinazoline,
Structural Analogues and Related Compounds
Skin
Duration Total tumours carcinomas
Number of ,-1------1
ofmice experimnent Per- Per-
Compound at risk (days) Number centage Number centage
TCQ (I) * * * 36 . 471 . 29 81 . 27 75 CompoundlI . . . 37 . 556 . 11 31 . 0 0
Tri-o-xylylamine (III) . 27 . 419 1 4 . 0 0
Iso-TCQ (IV) FreeBase . 36 . 558 2 6 . 0 0 Iso.TCQ Nitrate . 44 595 . 6 14 . 2 5
Compound(V). . . 38 . 534 . 4 11 . 1 3
Compound(VI) . 37 . 488 . 0 0 0 0
Compound(VIII) . 37 . 609 1 3 . 1 3
Phenanthroline (X) . . 37 556 . 2 5 . 0 0
Quinazoline (XI) . . 35 488 . 3 9 . 0 0
4-Hydroxyquinazoline (XII) . 38 . 486 . 2 5 . 0 0
Benzene (Control) . . 58 518 4 7 4 7
These results clearly indicate that modification of the symmetrical structure
of TCQ greatly reduces carcinogenic activity. Thus iso-TCQ base proved to be
virtually inactive, tumours developing in only 2 mice (6 per cent). The response
elicited by iso-TCQ nitrate in aqueous acetone was slightly greater, tumours
developing in 6 mice (14 per cent), but this tumour incidence is low compared to
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that produced with tricycloquinazoline (81 per cent). Further modification of
the iso-TCQ structure was without significant influence on carcinogenicity.
Thus the oxygen isostere of iso-TCQ (compound V), which is structurally similar
to iso-TCQ, but resembles TCQ more closely in its basic properties was only weakly
active (tumour incidence 11 per cent). Furthermore the iso-TCQ derivative
modified by loss ofa benzene ring (compound VI, Table I) was completely inactive.
In contrast, the hexacyclic compound II, which has a structure intermediate
between that of TCQ and iso-TCQ, showed some activity, tumours developing in
11 (31 per cent) of mice at risk. This activity is low, however, compared with
that of TCQ (total incidence 81 per cent) and, moreover, none of the tumours
induced with compound II was found to be malignant, the majority being squa-
mous papillomata together with an occasional sebaceous adenoma. There were
also marked differences in the latent period for tumour induction. Thus with
TCQ, tumours mainly developed between the 4th and 8th month of treatment.
whereas the majority of tumours induced with compound II arose after skin
painting was completed (12 months).
Tri-o-xylylamine (III) was examined since this compound should be able to
assume a conformation similar to that of TCQ (Fig. 1). However it was without
significant carcinogenic activity, even though the total dose skin painted (100
mg.) was approximately four times greater than that of TCQ.
DISCUSSION
The inactivity of the triazabenzanthracene (VIII) and the phenanthroline (X),
both of which have some structural features comparable with TCQ, further
supports the hypothesis that the overall molecular shape of TCQ is critical for
carcinogenesis. In addition, the findings with the phenanthroline (X) contrast
with the carcinogenic activity observed with related homocyclic compound
benzo[c]phenanthrene (Hartwell, 1951). Although the carcinogenicity of TCQ
cannot be interpreted in terms of the K region hypothesis (Pullman and Pullman,
1955), it is perhaps significant that in the inactive phenanthroline, the positions
corresponding to the K regions in benzo[c]phenanthrene are blocked by aza
substitution.
The mode of TCQ metabolism is still not fully determined, but studies so far
completed indicate that considerable degradation occurs. None of these meta-
bolites have yet been identified but it is feasible that hydroxylated quinazolines
may be formed. Hence the virtual inactivity of quinazoline and 4-hydroxyquin-
azoline (Table II) supports the hypothesis originally developed from studies on the
influence of peripheral ring substitution on the carcinogenic activity of TCQ
(Baldwin, Cunningham, Partridge and Vipond, 1962) that the whole molecule
rather than a metabolite is the proximate carcinogen.
In iso-TCQ (IV, Fig. I) the position of one of the peripheral benzene rings is
altered so that the molecule no longer possesses a symmetrical structure. How-
ever the orientation of the other five rings is identical with that of TCQ and thus
the inactivity of iso-TCQ suggests that the overall molecular shape and size of
TCQ are important for carcinogenicity. This hypothesis gains additional support
from the inactivity of compounds V and VI, since although they are structurallv
related to iso-TCQ they still possess some structural features in common with TCQ.
Moreover, it is perhaps significant that compound II showed some activity inducing
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skin papillomata in 31 per cent of mice at risk, since its molecular shape is inter-
mediate between that of TCQ and iso-TCQ (Fig. I).
A characteristic structural feature of TCQ which may be critical for carcino-
genesis is the amidine arrangement of the nitrogen atoms. Thus in iso-TCQ and
the related compounds (V and VI), all ofwhich were virtually inactive, in addition
to the change in molecular shape, the distribution of nitrogen atoms is also
altered. In contrast the finding of some activity with compound II suggests that
the number and arrangement of nitrogen atoms is not the critical requirement for
carcinogenesis. However, the activity of compound II was low compared with
that of TCQ (total tumour incidences 31 and 81 per cent respectively) and none
of the tumours induced by compound II proved to be malignant. Clearly,
therefore, further studies are necessary to ascertain the importance ofthe number
* 1 1...S~~- 6.
FIG. 2.-Stereochemical fit of TCQ to purine and pyrimidine base pair of DNA.
and arrangement of nitrogen atoms in TCQ. For this purpose, isosteres of TCQ
have been prepared in which one or more of the nitrogen atoms are replaced
by = CH-groups and these compounds are now under investigation.
Implicit in the changes in carcinogenicity induced by peripheral ring sub-
stitution in TCQ (Baldwin, Cunningham, Partridge and Vipond, 1962) is the
requirement for high activity of a precise stereochemical fit of the carcinogen to a
tissue receptor. The weak activity of iso-TCQ thus provides further evidence of
the importance of stereochemical factors in TCQ carcinogenesis.
The absence of any indication of strong binding of TCQ to tissue (Baldwin,
Palmer and Partridge, 1962) excludes the possibility of covalent bonding to cell
receptor and thus multiple bonding by low-energy bonds is evidently involved.
Iso-TCQ has different possibilities for bonding to a structurally specific tissue
receptor by overlap of 1-orbitals, by hydrogen bonding or by dipole-dipole or
dipole-ion interactions. The possibility of multiple van der Waals bonding of
TCQ and iso-TCQ to a non-specific cell receptor would probably not be sub-
stantially different. Hence the inactivity of iso-TCQ indicates that multiple
van der Waals bonding of TCQ is unlikely to be the decisive interaction between
the carcinogen and the cell. Evidently a multiplicity ofone or more ofthe above-
mentioned types of specific bond is involved in this interaction.
The sensitivity of carcinogenesis by TCQ and closely related compounds to
change in chemical structure, the planarity ofTCQ and the amidine arrangement of
its nitrogen atoms, together with this indication of specificity in the type of
bonding between the carcinogen and the receptor may berelevant to the possibility
270CARCINOGENICITY OF TRICYCLOQUINAZOLINE 271
of the bonding of TCQ to the planar, bonded purine and pyrimidine pairs in
DNA (Fig. 2).
SUMMARY
1. Modification of the arrangement of the homocycic and heterocyclic rings
of tricycloquinazoline, TCQ, results in almost complete loss of carcinogenic
activity. These findings thus indicate that the overall molecular shape and size
of TCQ are important for carcinogenicity. This hypothesis is further supported
by the finding of tumorigenic activity with a hexacyclic compound which has a
molecular shape intermediate between that of TCQ and the inactive isomer,
iso-TCQ.
2. No simpler azapolycycic compound related to TCQ has been found to
have significant carcinogenic activity, further supporting the concept that the
overall molecular shape of TCQ is critical for carcinogenicity. The inactivity
of quinazoline and 4-hydroxyquinazoline, two possible metabolites of TCQ,
provides corroborative evidence.
3. The implications of these findings to the mechanism of interaction of TCQ
with cell receptors are discussed.
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